Opus Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.85

-0.20 (-3.96%)

As of Sep 29, 2:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +378.6% upside

Low Target $16.63

Average Target $23.21

High Target $31.03

Current Price $4.85

Current
$4.85

Target
$23.21

$16.63 $23.21 avg $31.03

Scenario Analysis

Bear Case

$16.63

242.9%

Low target

Base Case

$23.21

+378.6%

Avg target

Bull Case

$31.03

+539.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$7.07

-31.4% from high

52-Week Low

$1.50

+223.3% from low

Target vs 52W High

$23.21

+228.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%